Remove Packaging Remove Pharmaceutical Companies Remove Vaccines
article thumbnail

IMA: the all-in-one solutions provider for complete vaccines lines

European Pharmaceutical Review

Even with extremely rapid vaccine development, limitations in production capabilities can have real-life implications. This has led pharmaceutical equipment manufacturers to react quickly, while maintaining due levels of diligence and social responsibility.

Vaccines 104
article thumbnail

Prefilled syringes and vaccines: Optimising parenteral packaging for the next pandemic

Pharmaceutical Technology

When it comes to vaccines and other high-value biologics, it is essential that effective formulations go hand in hand with safe delivery. An example is the ability of a patient suffering from venous thrombosis to perform their own injections of heparin – an anticoagulant often packaged in a prefilled syringe.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Next Generation RNA Therapeutics and Vaccines – A Marvel of The Lifesciences Industry

Roots Analysis

The next generation RNA therapeutics and RNA vaccines pipeline currently features the presence of more than 20 circular RNA therapeutics and vaccines, being developed across initial stages of drug development (discovery and preclinical).

article thumbnail

Uruguay progresses towards developing its first regulatory agency

Pharmaceutical Technology

How will RFK Jr’s American dream for vaccines play out? The government therefore is advocating for the creation of the new drug regulatory agency to expedite economic growth, streamline drug approvals and attract international pharmaceutical companies to invest in the country.

article thumbnail

How automation can help to address supply chain challenges in pharma

pharmaphorum

To combat such challenges, pharmaceutical companies need to adopt processes that are not just efficient, but agile. Empowering labs with automated equipment that produces rich, traceable, and actionable data insights means pharmaceutical companies can ensure drug production runs smoothly – even under stress.

article thumbnail

ten23 health Joins Gerresheimer, SCHOTT, Stevanato Group in ‘Alliance for RTU’

PharmTech

Shifts in sterile manufacturing include isolator tech adoption and packaging tailored to personalized medicine, at-home use, and chronic disease treatments. Pharmapack Europe 2025: Packaging Trends. At that time, Mahler said revisions to regulatory guidance were having an impact on fill/finish facilities. References 1. ten23 health.

Dosage 45
article thumbnail

UK manufacturing and R&D to benefit from new £360m investment

European Pharmaceutical Review

On 4 March, ahead of the Spring Budget , the UK Chancellor of the Exchequer, Jeremy Hunt, announced a significant investment package for the UK life sciences and manufacturing sectors. million will support two pharmaceutical companies investing a combined £84 million to expand their manufacturing plants in the UK. A sum of £7.5